e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Respiratory and skeletal muscle
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of CPAP treatment on muscle strength in OSAS and OS patients
A. Nowinski, P. Bielen, R. Plywaczewski, J. Zielinski, P. Sliwinski (Warsaw, Poland)
Source:
Annual Congress 2002 - Respiratory and skeletal muscle
Session:
Respiratory and skeletal muscle
Session type:
Thematic Poster Session
Number:
3122
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nowinski, P. Bielen, R. Plywaczewski, J. Zielinski, P. Sliwinski (Warsaw, Poland). Effects of CPAP treatment on muscle strength in OSAS and OS patients. Eur Respir J 2002; 20: Suppl. 38, 3122
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The physiology of breathlessness
Related content which might interest you:
Effects of CPAP treatment on exercise performance and gas exchange in OSAS and OS patients
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Effects of CPAP treatment in UARS patients comparing to OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Effect of CPAP adherence on depression in OSA patient
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Effects of respiratory muscle training (RMT) in patients with OSAS
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 335s
Year: 2007
Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Evaluation of cerebral metabolism after CPAP treatment in OSAS patients
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
CPAP treatment induces changes in lung diffusion in OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS
Source: Eur Respir J 2005; 26: Suppl. 49, 722s
Year: 2005
Predictors of compliance with CPAP in patients with OSA and metabolic syndrome
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005
Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Effects of inspiratory muscle training in patients with asthma
Source: International Congress 2017 – Assessment and treatment of respiratory muscle function in respiratory physiotherapy
Year: 2017
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
CPAP setting prediction in OSAS patients
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011
CPAP increases bronchial reactivity in OSAS patients
Source: Eur Respir Rev 2008; 17: 101-102
Year: 2008
CPAP increases bronchial reactivity in OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept